Work

The effect of dapagliflozin across the spectrum of baseline risk: a post-hoc analysis of DAPA-HF

Year: 2020

Type: article

Source: European Heart Journal

DOI: 10.1093/ehjci/ehaa946.0931

Authors: K.F Docherty, P.S Jhund, O Bengtsson, D.L Demets, S.E Inzucchi, L Kober, M.N Kosiborod, A.M Langkilde, D Lindholm, F.A Martinez, P Ponikowski, M.S Sabatine, M Sjostrand, S.D Solomon, J.J.V McMurray

Institutions: University of Glasgow, AstraZeneca (Sweden), University of Wisconsin–Madison, Yale University, Copenhagen University Hospital, Rigshospitalet, Saint Luke's Hospital, Universidad Nacional de Córdoba, Wroclaw Medical University, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3110105288

FWCI: 0.313

Cites:

Cited by: 2

Related to: 10